Scientific Sessions 2025  /  Defining Success in EP Clinical Trials  /  AF burden, time to recurrent AF, or quality of life: how the choice of endpoint impacts our field.
Logo

American Heart Association

  31
  0

Final ID:

AF burden, time to recurrent AF, or quality of life: how the choice of endpoint impacts our field.

  • Albert, Christine  ( Cedars-Sinai Medical Center , Los Aeles , California , United States )
  • Winterfield, Jeffrey  ( MUSC , Charleston , South Carolina , United States )
    • Author Disclosures:
    Christine Albert: DO have relevant financial relationships ; Consultant:Bayor:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Element Science:Active (exists now) | Jeffrey Winterfield: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Defining Success in EP Clinical Trials

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
The ADVENT Trial. Pulsed Field vs Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation: Recurrent Atrial Arrhythmia Burden

Reddy Vivek, Mansour Moussa

VANISH2 Trial: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

Sapp John

More abstracts from these authors:
Protecting first faculty appointments

Albert Christine

Discussant: OCEAN

Albert Christine

You have to be authorized to contact abstract author. Please, Login
Not Available